ahlam1399
09-06-2016, 05:02 PM
Danaher to buy Cepheid in $4 billion deal to expand in diag**stics
(Reuters) - Danaher Corp said on Tuesday it would buy molecular diag**stics company Cepheid in a deal valued at $4 billion, including debt, to strengthen its diag**stics business.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=JHm_UuR7v3U:fsxxEiXtGTU:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=JHm_UuR7v3U:fsxxEiXtGTU:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=JHm_UuR7v3U:fsxxEiXtGTU:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=JHm_UuR7v3U:fsxxEiXtGTU:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=JHm_UuR7v3U:fsxxEiXtGTU:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/JHm_UuR7v3U
(Reuters) - Danaher Corp said on Tuesday it would buy molecular diag**stics company Cepheid in a deal valued at $4 billion, including debt, to strengthen its diag**stics business.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=JHm_UuR7v3U:fsxxEiXtGTU:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=JHm_UuR7v3U:fsxxEiXtGTU:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=JHm_UuR7v3U:fsxxEiXtGTU:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=JHm_UuR7v3U:fsxxEiXtGTU:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=JHm_UuR7v3U:fsxxEiXtGTU:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/JHm_UuR7v3U